Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-19

Clinical Trial Update: High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating high-dose vitamin D supplementation for chronic spontaneous urticaria, sponsored by Shiraz University of Medical Science…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Urticaria | Phase 3 | Status: UNKNOWN